Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab
Ilenia Calcaterra/LinkedIn
May 5, 2026, 11:06

Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab

Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:

“Honored to have presented our work on hypertrophic synovium in severe haemophilia A during the moderated poster session at the WFH 2026 World Congress in Kuala Lumpur.

It was a real privilege to be among the candidates for the Christine Lee Young Researcher Award for best poster and to share this moment with such talented young researchers from around the world.

Our study, RESOLVE, focused on changes in hypertrophic synovium in adult patients with severe haemophilia A receiving emicizumab prophylaxis.

The data suggest that while emicizumab provides excellent bleed control, meaningful improvement in synovial status can also be observed, reinforcing the importance of joint monitoring and individualized joint health management.

Grateful for this opportunity, for the scientific exchange, and for the chance to contribute to ongoing research in haemophilia care.”

Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab

Find more posts featuring Ilenia Calcaterra on Hemostasis Today.

Emicizumab haemophilia A Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Ilenia Calcaterra Medicine RESOLVE WFH 2026 World Congress
NewsFeed